BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38050231)

  • 1. Anti-Nasopharyngeal carcinoma mechanism of sanguinarine based on network pharmacology and molecular docking.
    Fan JY; Liu J; Zhang WQ; Lin T; Hu XR; Zhou FL; Tang L; He YC; Shi HJ
    Medicine (Baltimore); 2023 Dec; 102(48):e36477. PubMed ID: 38050231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteolin Isolated from
    Xiong Y; Zhong W; Liu J; Cheng B; Fan J; Zhou F; He L; Tian D; He Y
    Biomed Res Int; 2022; 2022():9740066. PubMed ID: 36588531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the Molecular Mechanism of
    Xu R; Yang X; Tao Y; Luo W; Xiong Y; He L; Zhou F; He Y
    J Healthc Eng; 2022; 2022():6277139. PubMed ID: 35463684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the pharmacological mechanisms of Biyan Qingdu Granula in the treatment after nasopharyngeal carcinoma radiotherapy based on UPLC/Q-TOF MS, network pharmacology and molecular docking.
    Yi B; Lv F; Zhang N; Lin J; Xu K; Li C; Li P; Zhao M
    J Pharm Biomed Anal; 2024 Feb; 239():115830. PubMed ID: 38096633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network pharmacology, molecular docking and experimental study of CEP in nasopharyngeal carcinoma.
    Yang J; Qin L; Zhou S; Li J; Tu Y; Mo M; Liu X; Huang J; Qin X; Jiao A; Wei W; Yang P
    J Ethnopharmacol; 2024 Apr; 323():117667. PubMed ID: 38159821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
    Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
    Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.
    Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y
    J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network pharmacology and experimental verification of the potential mechanism of Er-Xian decoction in aplastic anemia.
    Ye M; Liu G; Yang Y; Yang H; Ren J; Chen W; Gao Z
    Sci Rep; 2023 Oct; 13(1):17385. PubMed ID: 37833363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Assessment of
    Shi H; Liu J; Fan J; He L; Wang X; Tang F; Tian D; He Y
    Evid Based Complement Alternat Med; 2022; 2022():1988378. PubMed ID: 35178099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of the Molecular Mechanism of Polygonati Rhizoma in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking.
    Zhao J; Lin F; Liang G; Han Y; Xu N; Pan J; Luo M; Yang W; Zeng L
    Front Endocrinol (Lausanne); 2021; 12():815891. PubMed ID: 35069454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of the potential mechanism of compound gingerol against liver cancer based on network pharmacology and experimental verification.
    Su M; Wang X; Cao G; Sun L; Ho RJY; Han Y; Hong Y; Wu D
    J Pharm Pharmacol; 2022 Jun; 74(6):869-886. PubMed ID: 35429380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
    Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
    Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the mechanism and experimental validation of Fuzi Lizhong Tang in treating gastric cancer based on network pharmacology and molecular docking.
    Zhang FY; Guo SC
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9192-9204. PubMed ID: 37843333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of Bupleurum scorzonerifolium and Paeonia lactiflora herbal pair against liver cancer: an exploration based on UPLC-Q-TOF-MS combined with network pharmacology].
    Zou X; Sui Y; Tang XY; Zhang R; Shu Q; Gong T; Wu S; Sun ZW; Li WL; Qu ZY
    Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(13):3597-3608. PubMed ID: 35850814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of the Effect and Potential Mechanism of Echinacoside Against Endometrial Cancer Based on Network Pharmacology and in vitro Experimental Verification.
    Shu W; Wang Z; Zhao R; Shi R; Zhang J; Zhang W; Wang H
    Drug Des Devel Ther; 2022; 16():1847-1863. PubMed ID: 35734366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network-based Pharmacology and
    Long X; Chen L; Yang J; Dong T; Cheng Q; Wang W; Zou Y; Su Y; Dai W; Chen B; Zhou X
    Anticancer Agents Med Chem; 2023; 23(7):847-857. PubMed ID: 36305128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network pharmacology identification and in Vivo validation of key pharmacological pathways of Phyllanthus reticulatus (Euphorbiaceae) leaf extract in liver cancer treatment.
    Tang Y; Sun L; Wei J; Sun C; Gan C; Xie X; Liang C; Peng C; Wu H; Zheng Z; Pan Z; Huang Y
    J Ethnopharmacol; 2022 Oct; 297():115479. PubMed ID: 35777610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma.
    Han X; Liang L; He C; Ren Q; Su J; Cao L; Zheng J
    BMC Complement Med Ther; 2023 Nov; 23(1):422. PubMed ID: 37990309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.